Humana Inc.
HUM
$245.77
-$0.22-0.09%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 31.00B | 30.98B | 30.78B | 28.03B | 28.28B |
| Total Other Revenue | 1.65B | 1.41B | 1.34B | 1.18B | 1.11B |
| Total Revenue | 32.65B | 32.39B | 32.11B | 29.21B | 29.40B |
| Cost of Revenue | 27.99B | 27.57B | 26.54B | 25.38B | 25.12B |
| Gross Profit | 4.66B | 4.82B | 5.58B | 3.83B | 4.28B |
| SG&A Expenses | 3.82B | 3.49B | 3.36B | 3.84B | 3.28B |
| Depreciation & Amortization | 173.00M | 178.00M | 183.00M | 208.00M | 210.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.98B | 31.23B | 30.07B | 29.43B | 28.61B |
| Operating Income | 667.00M | 1.16B | 2.04B | -213.00M | 783.00M |
| Income Before Tax | 108.00M | 722.00M | 1.65B | -899.00M | 635.00M |
| Income Tax Expenses | -86.00M | 179.00M | 406.00M | -216.00M | 155.00M |
| Earnings from Continuing Operations | 194.00M | 543.00M | 1.24B | -683.00M | 480.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | 2.00M | 2.00M | -10.00M | -- |
| Net Income | 195.00M | 545.00M | 1.24B | -693.00M | 480.00M |
| EBIT | 667.00M | 1.16B | 2.04B | -213.00M | 783.00M |
| EBITDA | 871.00M | 1.37B | 2.25B | 27.00M | 1.03B |
| EPS Basic | 1.62 | 4.52 | 10.31 | -5.75 | 3.99 |
| Normalized Basic EPS | 2.28 | 4.08 | 8.68 | -3.04 | 3.58 |
| EPS Diluted | 1.62 | 4.51 | 10.30 | -5.76 | 3.98 |
| Normalized Diluted EPS | 2.28 | 4.07 | 8.66 | -3.04 | 3.57 |
| Average Basic Shares Outstanding | 120.27M | 120.54M | 120.67M | 120.46M | 120.41M |
| Average Diluted Shares Outstanding | 120.75M | 120.75M | 120.84M | 120.46M | 120.76M |
| Dividend Per Share | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 |
| Payout Ratio | 54.87% | 19.45% | 8.68% | -15.58% | 22.29% |